Biogen Idec (BIIB) Share Price Declined While First American Bank Has Increased Stake; Uss Investment Management LTD Decreased Stake in Extra Space Storage (EXR) by $2.20 Million as Stock Value Rose

Biogen Inc. (NASDAQ:BIIB) Logo

Uss Investment Management Ltd decreased its stake in Extra Space Storage Inc (EXR) by 7.84% based on its latest 2018Q4 regulatory filing with the SEC. Uss Investment Management Ltd sold 24,400 shares as the company’s stock rose 2.68% with the market. The institutional investor held 286,800 shares of the real estate investment trusts company at the end of 2018Q4, valued at $25.95 million, down from 311,200 at the end of the previous reported quarter. Uss Investment Management Ltd who had been investing in Extra Space Storage Inc for a number of months, seems to be less bullish one the $13.30B market cap company. The stock decreased 0.27% or $0.27 during the last trading session, reaching $99.78. About 1.79 million shares traded or 100.40% up from the average. Extra Space Storage Inc. (NYSE:EXR) has risen 12.16% since March 17, 2018 and is uptrending. It has outperformed by 7.79% the S&P500. Some Historical EXR News: 17/05/2018 – Dir Skousen Gifts 500 Of Extra Space Storage Inc; 24/05/2018 – EXTRA SPACE STORAGE QTRLY DIVIDEND 86C/SHR VS 78C/SHR; EST. 78C; 01/05/2018 – Extra Space Storage 1Q Net $88.3M; 15/05/2018 – Zurich Insurance Adds Extra Space, Exits Broadcom: 13F; 24/05/2018 – EXTRA SPACE STORAGE RAISES DIVIDEND 10.3%; 01/05/2018 – Extra Space Storage Sees 2018 FFO $4.53/Shr-FFO $4.62/Shr; 24/05/2018 – Extra Space Storage Inc. Announces A 10.3% Increase To Quarterly Common Dividend; 01/05/2018 – Extra Space Storage 1Q EPS 70c

First American Bank increased its stake in Biogen Idec Inc (BIIB) by 19.32% based on its latest 2018Q4 regulatory filing with the SEC. First American Bank bought 1,302 shares as the company’s stock declined 1.50% while stock markets rallied. The institutional investor held 8,041 shares of the biological products (no diagnostic substances) company at the end of 2018Q4, valued at $2.42 million, up from 6,739 at the end of the previous reported quarter. First American Bank who had been investing in Biogen Idec Inc for a number of months, seems to be bullish on the $64.89B market cap company. The stock increased 2.60% or $8.35 during the last trading session, reaching $329.87. About 2.37M shares traded or 78.20% up from the average. Biogen Inc. (NASDAQ:BIIB) has risen 15.91% since March 17, 2018 and is uptrending. It has outperformed by 11.54% the S&P500. Some Historical BIIB News: 12/03/2018 – BIOGEN DEAL INCL UP TO $515M ADDED MILESTONE PAYMENTS; 27/03/2018 – ICCR: Shareholders Will Vote on Resolutions at AbbVie, Amgen, Biogen, Bristol-Myers Squibb and Eli Lilly; 24/04/2018 – BIOGEN INC – QTRLY AVONEX REVENUE OF $451 MLN VS $537 MLN REPORTED LAST YEAR; 07/05/2018 – Biogen’s Tecfidera Falls After 1-Wk Rise, Copaxone Declines: MS; 07/03/2018 – EMA – EMA’S RECOMMENDATION TO SUSPEND ZINBRYTA AND RECALL THE PRODUCT IS BEING SENT TO THE EUROPEAN COMMISSION FOR A LEGALLY BINDING DECISION; 20/04/2018 – DJ Biogen Inc, Inst Holders, 1Q 2018 (BIIB); 05/04/2018 – $ABBV $BIIB Settlement on Humira #Biosimilar in Europe -; 24/04/2018 – Biotech Drug Production Pipeline Increasing Amid Buzz of Market Optimism; 20/04/2018 – BIOGEN & IONIS EXPAND STRATEGIC PACT TO DEVELOP DRUG CANDIDATES; 20/04/2018 – Biogen, Ionis Expect to Close Deal in 2Q

Since September 26, 2018, it had 1 insider buy, and 1 sale for $20.22 million activity. On Wednesday, January 30 the insider DENNER ALEXANDER J bought $20.57 million.

More notable recent Biogen Inc. (NASDAQ:BIIB) news were published by: Seekingalpha.com which released: “Biogen’s Spinraza OK’d in China – Seeking Alpha” on February 28, 2019, also Streetinsider.com with their article: “Alkermes (ALKS) and Biogen (BIIB) Announce FDA Acceptance of Diroximel Fumarate NDA for MS – StreetInsider.com” published on February 25, 2019, Nasdaq.com published: “IBB, CELG, BIIB, GILD: Large Inflows Detected at ETF – Nasdaq” on March 14, 2019. More interesting news about Biogen Inc. (NASDAQ:BIIB) were released by: Nasdaq.com and their article: “AbbVie’s RA Candidate Upadacitinib Gets FDA Priority Review – Nasdaq” published on February 20, 2019 as well as Nasdaq.com‘s news article titled: “Better Buy: Amgen vs. Biogen – Nasdaq” with publication date: March 10, 2019.

Investors sentiment decreased to 0.91 in Q4 2018. Its down 0.10, from 1.01 in 2018Q3. It worsened, as 79 investors sold BIIB shares while 314 reduced holdings. 83 funds opened positions while 276 raised stakes. 181.17 million shares or 8.34% more from 167.21 million shares in 2018Q3 were reported. Quantbot Techs LP holds 2,902 shares or 0.09% of its portfolio. Greenleaf Tru owns 0.02% invested in Biogen Inc. (NASDAQ:BIIB) for 2,559 shares. Bainco Investors reported 0.89% stake. Primecap Mngmt Ca has 3.59% invested in Biogen Inc. (NASDAQ:BIIB) for 14.72 million shares. Hills Bankshares & has invested 0.46% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Capital Fund Sa owns 7,327 shares for 0.02% of their portfolio. Virginia Retirement Sys Et Al invested in 0.32% or 78,100 shares. Calamos Advisors Ltd Co invested in 92,628 shares. Citigroup owns 241,553 shares. Millennium Management reported 76,842 shares. The Illinois-based Archford Cap Strategies Ltd has invested 0.01% in Biogen Inc. (NASDAQ:BIIB). Moreover, Rathbone Brothers Public Limited Co has 0.04% invested in Biogen Inc. (NASDAQ:BIIB). Old Dominion Cap Management Incorporated owns 21,021 shares. Fosun Limited owns 2,000 shares for 0.04% of their portfolio. Pub Employees Retirement Of Ohio stated it has 0.24% of its portfolio in Biogen Inc. (NASDAQ:BIIB).

First American Bank, which manages about $1.28B US Long portfolio, decreased its stake in Procter & Gamble (NYSE:PG) by 3,947 shares to 115,153 shares, valued at $10.59 million in 2018Q4, according to the filing. It also reduced its holding in Cisco Sys Inc Com (NASDAQ:CSCO) by 10,183 shares in the quarter, leaving it with 201,288 shares, and cut its stake in Primecap (POAGX).

Since September 19, 2018, it had 0 insider buys, and 7 insider sales for $575,164 activity.

Uss Investment Management Ltd, which manages about $8.11 billion US Long portfolio, upped its stake in Travelers Companies Inc (NYSE:TRV) by 10,500 shares to 85,900 shares, valued at $10.29M in 2018Q4, according to the filing. It also increased its holding in Cdk Global Inc (NASDAQ:CDK) by 15,300 shares in the quarter, for a total of 179,300 shares, and has risen its stake in Aflac Inc (NYSE:AFL).

Investors sentiment decreased to 0.94 in Q4 2018. Its down 0.24, from 1.18 in 2018Q3. It is negative, as 31 investors sold EXR shares while 144 reduced holdings. 43 funds opened positions while 121 raised stakes. 121.50 million shares or 0.33% less from 121.91 million shares in 2018Q3 were reported. Taylor Frigon Capital Management Limited Liability invested 0.92% of its portfolio in Extra Space Storage Inc. (NYSE:EXR). Cibc Markets reported 0.01% of its portfolio in Extra Space Storage Inc. (NYSE:EXR). Gsa Capital Ptnrs Llp owns 0.03% invested in Extra Space Storage Inc. (NYSE:EXR) for 3,155 shares. Vident Inv Advisory Ltd owns 14,800 shares. First Republic Inv Incorporated holds 0.09% of its portfolio in Extra Space Storage Inc. (NYSE:EXR) for 165,721 shares. Earnest Ptnrs Lc stated it has 59 shares. Atria Investments Limited Liability Corporation has 0.09% invested in Extra Space Storage Inc. (NYSE:EXR). 173 are owned by Commonwealth Retail Bank Of. Moreover, Royal London Asset Mgmt Ltd has 0.04% invested in Extra Space Storage Inc. (NYSE:EXR) for 50,542 shares. Fca Tx invested in 0.13% or 2,500 shares. The United Kingdom-based Barclays Public Ltd Co has invested 0.02% in Extra Space Storage Inc. (NYSE:EXR). Bridgewater Associates Limited Partnership invested 0% of its portfolio in Extra Space Storage Inc. (NYSE:EXR). Guardian Life Insur Of America holds 0.01% of its portfolio in Extra Space Storage Inc. (NYSE:EXR) for 356 shares. Gateway Invest Advisers stated it has 229,265 shares or 0.2% of all its holdings. Sei Investments accumulated 0.08% or 264,583 shares.

Extra Space Storage Inc. (NYSE:EXR) Institutional Positions Chart